TUSTIN, Calif., Feb 02, 2010 /PRNewswire via COMTEX News Network/ -- Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) today announced that senior management will present at the 12th Annual BIO CEO & Investor Conference on Tuesday, February 9, 2010 at 3:30 pm EST. The conference will be held at the Waldorf-Astoria Hotel in New York City.

A live webcast of the company's presentation will be available at the Investors section of Peregrine's website at www.peregrineinc.com.

For more information about this conference, please visit: http://www.ceo.bio.org/opencms/ceo/2010/

About Peregrine Pharmaceuticals

Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company with a portfolio of innovative product candidates in clinical trials for the treatment of cancer and serious virus infections. The company is pursuing three separate clinical programs in cancer and HCV infection with its lead product candidates bavituximab and Cotara(R). Peregrine also has in-house manufacturing capabilities through its wholly owned subsidiary Avid Bioservices, Inc. (www.avidbio.com), which provides development and bio-manufacturing services for both Peregrine and outside customers. Additional information about Peregrine can be found at www.peregrineinc.com.

    Contacts:
    GendeLLindheim BioCom Partners
    Investors                              Media
    ---------                              -----
    info@peregrineinc.com                  Barbara Lindheim
    (800) 987-8256                         (212) 918-4650

SOURCE Peregrine Pharmaceuticals, Inc.

Copyright (C) 2010 PR Newswire. All rights reserved